The BIOCAD company was founded in 2001. It is one of the largest international innovative biotechnology companies in Russia, combining world-class research centers, modern pharmaceutical and biotechnological production, preclinical and clinical research that meets international standards.
BIOCAD is a full–cycle company for the creation of medicines from the search for a molecule to mass production and marketing support. The company focuses on drugs for the treatment of oncological, autoimmune and infectious diseases, and also develops in the field of therapy of other socially significant diseases. The product portfolio includes more than 60 medicines, more than 20 of which are biological. About 25 more products are at different stages of development.